Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong Soon Choi

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
International Journal of Cancer|February 21, 2009
Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-alpha and stromal derived hepatocyte growth factorDong Soon Choi, Hyun-Jin Kim, Jong-Hyuck Yoon, et al.
Breast Cancer Research : BCR|September 7, 2018
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsRoberto R Rosato, Daniel Dávila-González, Dong Soon Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cellsWeijia Zhang, Kazuharu Kai, Dong Soon Choi, et al.
Gynecologic Oncology|June 23, 2009
Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaBJeong-Hyun Oh, Ji-Hye Kim, Hak-Jun Ahn, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast CancerDaniel Dávila-González, Dong Soon Choi, Roberto R Rosato, et al.
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.
Korean Journal of Orthodontics|May 26, 2026
Hypodontia in the Korean orthodontic population: Prevalence and characteristics of a nationwide multicenter studySung-Hun Kim, Yong-Il Kim, Seong-Sik Kim, et al.
Stem Cells (Dayton, Ohio)|May 10, 2014
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, et al.
Stem Cell Reports|December 19, 2017
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 PathwayYi Liu, Dong Soon Choi, Jianting Sheng, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
International Journal of Cancer|February 21, 2009
Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-alpha and stromal derived hepatocyte growth factorDong Soon Choi, Hyun-Jin Kim, Jong-Hyuck Yoon, et al.
Breast Cancer Research : BCR|September 7, 2018
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsRoberto R Rosato, Daniel Dávila-González, Dong Soon Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cellsWeijia Zhang, Kazuharu Kai, Dong Soon Choi, et al.
Gynecologic Oncology|June 23, 2009
Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaBJeong-Hyun Oh, Ji-Hye Kim, Hak-Jun Ahn, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast CancerDaniel Dávila-González, Dong Soon Choi, Roberto R Rosato, et al.
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.
Korean Journal of Orthodontics|May 26, 2026
Hypodontia in the Korean orthodontic population: Prevalence and characteristics of a nationwide multicenter studySung-Hun Kim, Yong-Il Kim, Seong-Sik Kim, et al.
Stem Cells (Dayton, Ohio)|May 10, 2014
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, et al.
Stem Cell Reports|December 19, 2017
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 PathwayYi Liu, Dong Soon Choi, Jianting Sheng, et al.
Pageof 6